CODY MIHILLS: Open Payments
NPI 1548246671 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,656 in 120 payments from 27 companies in 2025. Trend: 2023 $1,125 · 2024 $3,149 · 2025 $1,656
Food & beverage: $1,649Education: $7
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 33 | $254 |
| ABBVIE INC. | 26 | $244 |
| AstraZeneca Pharmaceuticals LP | 8 | $200 |
| Currax Pharmaceuticals LLC | 13 | $136 |
| Abbott Laboratories | 4 | $127 |
| Axsome Therapeutics, Inc. | 4 | $102 |
| Noven Therapeutics, LLC | 5 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Antares Pharma, Inc. | 3 | $47 |
| Novo Nordisk Inc | 2 | $42 |
Products named: CONTRAVE, OTEZLA, Xelstrym, AIRSUPRA, REPATHA, VRAYLAR, Kerendia, FARXIGA.
Industry payments across TX — which companies pay providers there.
